Aminosalicylic Acid Resin Complex

Generic Name: aminosalicylic acid resin complex

Over-the-Counter (OTC)

Manufactured by BRISTOL MYERS SQUIBB. Dosage form: POWDER. Route: ORAL. Active ingredients: AMINOSALICYLIC ACID RESIN COMPLEX (EQ 500MG BASE/GM). Application: NDA009052.

Overview

Manufactured by BRISTOL MYERS SQUIBB. Dosage form: POWDER. Route: ORAL. Active ingredients: AMINOSALICYLIC ACID RESIN COMPLEX (EQ 500MG BASE/GM). Application: NDA009052.

Dosage

Available as powder for oral use.

Related Medications

Capra Hircus

capra hircus

Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: CAPRA HIRCUS SKIN (.001 g/mL). Category: BLA.

Scopolamine Transdermal System

scopolamine transdermal system

Anticholinergic [EPC]

11 DESCRIPTION Scopolamine transdermal system is designed for continuous release of scopolamine following application to an area of intact skin on the head, behind the ear. Each system contains 1.3 mg of scopolamine base. Scopolamine is (9-methyl-3-oxa-9-azatricyclo[3.3.1.0 2,4 ]nonan-7-yl) 3-hydroxy-2-phenylpropanoate. The empirical formula is C 17 H 21 NO 4 and its structural formula is: Scopolamine has a molecular weight of 303.35 and a pKa of 7.55-7.81.

Angelica Archangelica, Kali Muriaticum, Yucca Filamentosa, Cartilago Suis, Phytolacca Decandra, Hydrastis Canadensis, Rhus Tox, Causticum, Magnesia Phosphorica, Manganum Metallicum, Oxalicum Acidum, Arnica Montana, Babesia Microti, Borrelia Burgdorferi Nosode, Latrodectus Mactans, Citricum Acidum, Cytomegalovirus Nosode, Rickettsia Nosode (rickettsia Prowazekii), Chlamydia Trachomatis, Ledum Palustre

angelica archangelica, kali muriaticum, yucca filamentosa, cartilago suis, phytolacca decandra, hydrastis canadensis, rhus tox, causticum, magnesia phosphorica, manganum metallicum, oxalicum acidum, arnica montana, babesia microti, borrelia burgdorferi nosode, latrodectus mactans, citricum acidum, cytomegalovirus nosode, rickettsia nosode (rickettsia prowazekii), chlamydia trachomatis, ledum palustre

Calculi Dissolution Agent [EPC]

INDICATIONS: Supports the immune system for host resistance to Lyme disease and co-infections.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.